CCS-Novo Nordisk Cardiometabolic Research Award
The Canadian Cardiovascular Society (CCS) and Novo Nordisk have collaboratively created an award, entitled “CCS-Novo Nordisk Cardiometabolic Research Award”.
This Award is intended for early career researchers (including PhDs and MDs) who are within five (5) years of their first faculty appointment at a Canadian academic institution, for a research project on any topic related to cardiometabolic disease.
A single award of $35K will be awarded based on an independent peer review process. Funded research must be completed within 12 months from the start of funding.
Eligibility
- Applicants must be or become members of the Canadian Cardiovascular Society before accepting the award. For more information about CCS Membership, visit the CCS Membership Page.
*You must be a CCS member to accept funding, but you can apply without being a member! - The principal investigator must be an early career researcher (ECR). An early career researcher (ECR) is a researcher within five years of the date of their first independent research-related appointment at an academic institution. Given that career progress for an ECR is particularly vulnerable to normal life circumstances, CCS will adjust the eligibility window, as per CIHR applications, as follows:
- Eligible leaves (e.g., maternity, parental, medical, family medical, bereavement) will extend ECR status (i.e., will not be counted towards the maximum) and are credited as twice the amount of time taken.
- No adjustments are provided for professional leaves (e.g., training, sabbatical, administrative). No adjustments are provided for time spent on non-research-related duties or for the pursuit of non-research-related career activities.
- Applicants must be a Canadian Citizen or Permanent Resident of Canada at the time of receiving funding.
- Co-applicants of different career stages can be included.
- Applicants can be principal investigators on only one application per cycle.
- Award funds are solely intended for research performed in Canada.
- The award and funds are intended for original research and should not supplement funding for that already have extramural funding.
- If the submission refers to a multicenter clinical trial, the applicant must specify their specific role in the research study.
- If the application is for a sub-study of an ongoing project or trial, the applicant must specify their role and explain how the sub-study is distinct from the main study.
- Funded research must be completed within 48 months from the start of funding.
The Award
One (1) award is available in 2025.
Award:
$35,000
Funds will be administered by the Cardiology Division of the awardee’s affiliated university or equivalent.
The Peer Review Process and Evaluation Committee
All applications will be pre-screened for eligibility. Applications that are late, incomplete and/or do not meet the basic eligibility criteria will not be considered for review. Peer review of all eligible applications will be conducted by a scientific review committee comprised of CCS members. All eligible proposals will be reviewed by at least two members of the peer review committee.
If you have any questions or require support preparing and submitting your application, please email researchawards@ccs.ca.
If you have any questions or require support preparing or submitting your application, please email researchawards@ccs.ca.
Supported by:
The Canadian Cardiovascular Society and Novo Nordisk are proud to support the CCS-Novo Nordisk Cardiometabolic Research Award. With this award, we hope to further research on the link between cardiovascular disease in diabetes to improve thelives of Canadians who are affected by these conditions, and their families
